This article was originally published here
Cardiovasc Diabetol. 2021, May 7; 20 (1): 99. doi: 10.1186 / s12933-021-01286-7.
ABSTRACT
RATIONAL: Approximately 50% of patients with...
Bigfoot Biomedical announced today that it has received $ 57 million in funding to commercialize its diabetes management program.
Madryn Asset Management provided funding for...